Cargando…
Pan-cancer Analysis of NEDD4L and Its Tumor Suppressor Effects in Clear Cell Renal Cell Carcinoma
The expression level of NEDD4L, an E3 ubiquitin ligase, has changed significantly in human cancers. In this study, we aimed to study the expression of NEDD4L in pan-carcinoma and its function in malignant tumors. We analyzed the gene expression level of NEDD4L in pan-cancer from The Cancer Genome At...
Autores principales: | Dong, Huiyue, Zhu, Ling, Sun, Jingjing, Zhang, Yi, Cui, Qiang, Wu, Lin, Chen, Shushang, Lu, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425189/ https://www.ncbi.nlm.nih.gov/pubmed/34539897 http://dx.doi.org/10.7150/jca.58004 |
Ejemplares similares
-
ABAT and ALDH6A1, regulated by transcription factor HNF4A, suppress tumorigenic capability in clear cell renal cell carcinoma
por: Lu, Jun, et al.
Publicado: (2020) -
Integrated bioinformatics analysis of the NEDD4 family reveals a prognostic value of NEDD4L in clear-cell renal cell cancer
por: Zhao, Hui, et al.
Publicado: (2021) -
Classification of Clear Cell Renal Cell Carcinoma based on Tumor Suppressor Genomic Profiling
por: Zhong, Weimin, et al.
Publicado: (2021) -
KDF1, a Novel Tumor Suppressor in Clear Cell Renal Cell Carcinoma
por: Zheng, Jing-min, et al.
Publicado: (2021) -
RNF43 is a novel tumor-suppressor and prognostic indicator in clear cell renal cell carcinoma
por: ZHU, DAWEI, et al.
Publicado: (2022)